Department of Oral and Maxillofacial Surgery, Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, P. R. China.
Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, QC, Canada.
Sci Rep. 2019 Jan 24;9(1):472. doi: 10.1038/s41598-018-36778-2.
Therapies using human mesenchymal stem cells (MSCs) combined with three-dimensional (3D) printed scaffolds are a promising strategy for bone grafting. But the harvest of MSCs still remains invasive for patients. Human synovial fluid MSCs (hSF-MSCs), which can be obtained by a minimally invasive needle-aspiration procedure, have been used for cartilage repair. However, little is known of hSF-MSCs in bone regeneration. Polyetherketoneketone (PEKK) is an attractive bone scaffold due to its mechanical properties comparable to bone. In this study, 3D-printed PEKK scaffolds were fabricated using laser sintering technique. hSF-MSCs were characterized and cultured on PEKK to evaluate their cell attachment, proliferation, and osteogenic potential. Rabbit calvarial critical-sized bone defects were created to test the bone regenerative effect of PEKK with hSF-MSCs. In vitro results showed that hSF-MSCs attached, proliferated, and were osteogenic on PEKK. In vivo results indicated that PEKK seeded with hSF-MSCs regenerated twice the amount of newly formed bone when compared to PEKK seeded with osteogenically-induced hSF-MSCs or PEKK scaffolds alone. These results suggested that there was no need to induce hSF-MSCs into osteoblasts prior to their transplantations in vivo. In conclusion, the combined use of PEKK and hSF-MSCs was effective in regenerating critical-sized bone defects.
利用人骨髓间充质干细胞(MSCs)与三维(3D)打印支架相结合的疗法是骨移植的一种有前途的策略。但 MSCs 的采集对患者仍然具有侵入性。人滑膜间充质干细胞(hSF-MSCs)可以通过微创的针吸程序获得,已被用于软骨修复。然而,关于 hSF-MSCs 在骨再生中的作用知之甚少。聚醚酮酮(PEKK)因其机械性能可与骨骼媲美,是一种有吸引力的骨支架。在这项研究中,使用激光烧结技术制造了 3D 打印的 PEKK 支架。对 hSF-MSCs 进行了特征描述并在 PEKK 上进行了培养,以评估其细胞附着、增殖和成骨潜力。通过在兔颅骨临界尺寸骨缺损中进行实验,以测试 PEKK 与 hSF-MSCs 联合应用的骨再生效果。体外结果表明,hSF-MSCs 可在 PEKK 上附着、增殖和成骨。体内结果表明,与经成骨诱导的 hSF-MSCs 或单独的 PEKK 支架相比,PEKK 上接种 hSF-MSCs 后再生的新骨量增加了一倍。这些结果表明,在体内移植前无需将 hSF-MSCs 诱导为成骨细胞。总之,PEKK 和 hSF-MSCs 的联合使用可有效再生临界尺寸的骨缺损。